Brief Synopsis
For this Briefing, we asked Prof. Ellen Heitzer and Georgios Vlachos from the Institute of Human Genetics, Medical University of Graz to share their experience in working with homologous recombination deficiency (HRD) testing. Join us to familiarize yourself with the concepts and approaches central to performing this type of testing and why it is important for precision oncology. Hope to see you there!
Join us on Wednesday, February 15th, 2023. 5PM CET/6PM EET
Please join the conversation and post your comments, thoughts and questions below leading up to the briefing.
VB03 Recording
See you inside. Members have full access to this document
Your North Star in the Transformation of Precision Oncology
Consider applying to access:
- Comprehensive Educational Programs
- Ongoing Professional Development
- Exclusive Access to the Vessel Community
Apply Now
Already have an account?
Member Login
See you inside. Members have full access to this document
Your North Star in the Transformation of Precision Oncology
Consider applying if you want to:
- Acquire in-depth knowledge and skills, enabling you to excel in your field.
- Continuously improve and stay relevant in your career through regular training and development opportunities, positioning you for career advancement
- Connect, network, and collaborate with like-minded professionals, gaining unique insights and opportunities that are only available to members of this community.
Apply Now
Already have an account?
Member Login